Skip to content
GLP-1 Scorecard
Menu
Site position #533

AM Rx

Published by GLP-1 ScorecardUpdated

AM Rx (getamrx.com) is a telehealth platform operated by FitRX, LLC (also operates Zealthy and FitRx).

Visit AM RxWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$151/mo (quarterly plan, plus a separate fee, compounded)
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Yes

Weigh AM Rx against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value51/100
Dose & formulation65/100
Clinical oversight41/100
Labs & monitoring49/100
Fulfillment58/100
Contract terms20/100

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

What to consider

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA issued FitRX, LLC dba AM RX a warning letter in June 2026; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).

Site position #533 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to FitRX, LLC dba AM RX in June 2026. See the FDA warning-letter database.

Visit AM Rx

Closest here

The rankings grading nearest AM Rx — the realistic shortlist.

Blue Haven RX#531

Blue Haven RX is a telehealth weight-loss program offering compounded GLP-1 on flat monthly pricing: semaglutide at $179/month and tirzepatide at $259/month, with the cost covering the doctor consultation, prescription, medication and free shipping (intro offers run as low as $149/month).

Tablet Health#532

Tablet Health is a DTC telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral forms, with ED and NAD+ wellness lines as well.

ClickSlim#534

Wyoming-registered telehealth selling compounded tirzepatide and NAD+ on introductory rates that step up after the first month, with no published state list.

Royal Medical Center#535

Royal Medical Center is a physician-led nationwide telehealth practice centered on hormone therapy that also offers a compounded tirzepatide weight-loss program (no semaglutide).

Wellorithm#527

Public first and ongoing injection prices, with unresolved monthly-versus-28-day billing and separately qualified oral and branded offers.

Remi Meds#536

Remi Meds is a DTC compounded-GLP-1 telehealth platform offering per-dose-tier compounded semaglutide and tirzepatide-with-B12, plus NAD+, Sermorelin, and Glutathione add-ons.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect AM Rx's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on AM Rx's site. Not medical advice; see our disclosure.

← Back to the scorecard